New scoring system for outflow tract arrhythmias with wide QRS
Part of Heart & circulation clinical trials.
This study is testing a new scoring system (called a Hybrid Score) to better predict the origin of ventricular arrhythmias coming from the outflow tract of the heart. The goal is to improve treatment planning for people with a wide QRS complex on their ECG.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a ventricular arrhythmia (extra or fast heartbeats from the lower chambers) that starts in the outflow tract of the heart.
- Your QRS width (a measurement on the ECG) is greater than 110 milliseconds (wider than normal).
- You are willing and able to sign a consent form to participate in the study.
- You have not had a previous catheter ablation procedure for this condition that failed.
- You do not have infrequent arrhythmia that would require a special mapping technique called pacemapping during ablation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to find the exact spot in the heart that causes rapid heartbeats, so doctors can treat it more precisely with a procedure called catheter ablation.
This study checks a more detailed kind of heart recording (ECG) using many small sensors to better measure electrical rhythm problems. It may help doctors refine how they assess risk in people with serious or suspected dangerous heart rhythm issues.
This trial tests a new way to treat dangerous fast heart rhythms from the lower heart chambers, using a technique called pulsed field ablation. It aims to see if this approach is safe and effective for people with frequent premature beats, sustained rapid heartbeats, or life-threatening rhythm problems.
This study uses a special ECG to better tell apart different types of fast heart rhythms in people scheduled for a procedure called ablation. The goal is to improve diagnosis and treatment for conditions like atrial fibrillation and other supraventricular tachycardias.
This trial tests a special catheter to map abnormal heart rhythms like ventricular tachycardia or atrial fibrillation. It may help patients who need a procedure to find and treat the source of these fast or irregular heartbeats.
This trial is testing a new approach to treating a fast, dangerous heart rhythm (ventricular tachycardia) that comes from scar tissue in people with ischemic cardiomyopathy. The goal is to use a special mapping technique to guide the ablation (a procedure that destroys the tiny area causing the problem) to stop the arrhythmia.
Hear when a new ECG trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.